A citation-based method for searching scientific literature

Raymund A C Roos. Orphanet J Rare Dis 2010
Times Cited: 451







List of co-cited articles
639 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Huntington disease.
Gillian P Bates, Ray Dorsey, James F Gusella, Michael R Hayden, Chris Kay, Blair R Leavitt, Martha Nance, Christopher A Ross, Rachael I Scahill, Ronald Wetzel,[...]. Nat Rev Dis Primers 2015
629
16


Huntington disease: natural history, biomarkers and prospects for therapeutics.
Christopher A Ross, Elizabeth H Aylward, Edward J Wild, Douglas R Langbehn, Jeffrey D Long, John H Warner, Rachael I Scahill, Blair R Leavitt, Julie C Stout, Jane S Paulsen,[...]. Nat Rev Neurol 2014
560
14

Huntington's disease: a clinical review.
P McColgan, S J Tabrizi. Eur J Neurol 2018
321
13

Huntington's disease.
Francis O Walker. Lancet 2007
12

The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis.
Tamara Pringsheim, Katie Wiltshire, Lundy Day, Jonathan Dykeman, Thomas Steeves, Nathalie Jette. Mov Disord 2012
286
11

Huntington's disease: from molecular pathogenesis to clinical treatment.
Christopher A Ross, Sarah J Tabrizi. Lancet Neurol 2011
945
11

The Prevalence of Huntington's Disease.
Michael D Rawlins, Nancy S Wexler, Alice R Wexler, Sarah J Tabrizi, Ian Douglas, Stephen J W Evans, Liam Smeeth. Neuroepidemiology 2016
137
10

Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Sarah J Tabrizi, Rachael I Scahill, Gail Owen, Alexandra Durr, Blair R Leavitt, Raymund A Roos, Beth Borowsky, Bernhard Landwehrmeyer, Chris Frost, Hans Johnson,[...]. Lancet Neurol 2013
505
10

The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease.
S E Andrew, Y P Goldberg, B Kremer, H Telenius, J Theilmann, S Adam, E Starr, F Squitieri, B Lin, M A Kalchman. Nat Genet 1993
809
9

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
M DiFiglia, E Sapp, K O Chase, S W Davies, G P Bates, J P Vonsattel, N Aronin. Science 1997
9


Data Analytics from Enroll-HD, a Global Clinical Research Platform for Huntington's Disease.
Georg B Landwehrmeyer, Cheryl J Fitzer-Attas, Joseph D Giuliano, Nilza Gonçalves, Karen E Anderson, Francisco Cardoso, Joaquim J Ferreira, Tiago A Mestre, Julie C Stout, Cristina Sampaio. Mov Disord Clin Pract 2016
95
8

The Biology of Huntingtin.
Frédéric Saudou, Sandrine Humbert. Neuron 2016
405
8

Detection of Huntington's disease decades before diagnosis: the Predict-HD study.
J S Paulsen, D R Langbehn, J C Stout, E Aylward, C A Ross, M Nance, M Guttman, S Johnson, M MacDonald, L J Beglinger,[...]. J Neurol Neurosurg Psychiatry 2008
552
7

Psychopathology in verified Huntington's disease gene carriers.
E van Duijn, E M Kingma, R C van der Mast. J Neuropsychiatry Clin Neurosci 2007
184
7

Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY).
Erik van Duijn, David Craufurd, Anna A M Hubers, Erik J Giltay, Raphael Bonelli, Hugh Rickards, Karen E Anderson, Marleen R van Walsem, Rose C van der Mast, Michael Orth,[...]. J Neurol Neurosurg Psychiatry 2014
136
7

Patient and caregiver quality of life in Huntington's disease.
Rebecca E Ready, Melissa Mathews, Anne Leserman, Jane S Paulsen. Mov Disord 2008
66
9

The global prevalence of Huntington's disease: a systematic review and discussion.
Sheharyar Sajjad Baig, Mark Strong, Oliver Wj Quarrell. Neurodegener Dis Manag 2016
53
11

Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.
Sarah J Tabrizi, Douglas R Langbehn, Blair R Leavitt, Raymund Ac Roos, Alexandra Durr, David Craufurd, Christopher Kennard, Stephen L Hicks, Nick C Fox, Rachael I Scahill,[...]. Lancet Neurol 2009
659
6

Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records.
Stephen J W Evans, Ian Douglas, Michael D Rawlins, Nancy S Wexler, Sarah J Tabrizi, Liam Smeeth. J Neurol Neurosurg Psychiatry 2013
112
6

Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.
Jane S Paulsen, Jeffrey D Long, Christopher A Ross, Deborah L Harrington, Cheryl J Erwin, Janet K Williams, Holly James Westervelt, Hans J Johnson, Elizabeth H Aylward, Ying Zhang,[...]. Lancet Neurol 2014
149
5

Behavioural abnormalities contribute to functional decline in Huntington's disease.
J M Hamilton, D P Salmon, J Corey-Bloom, A Gamst, J S Paulsen, S Jerkins, M W Jacobson, G Peavy. J Neurol Neurosurg Psychiatry 2003
122
5

Huntington disease: clinical care and evaluation.
I Shoulson, S Fahn. Neurology 1979
570
5


Targeting Huntingtin Expression in Patients with Huntington's Disease.
Sarah J Tabrizi, Blair R Leavitt, G Bernhard Landwehrmeyer, Edward J Wild, Carsten Saft, Roger A Barker, Nick F Blair, David Craufurd, Josef Priller, Hugh Rickards,[...]. N Engl J Med 2019
304
5


Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175.
Liliana B Menalled, Andrea E Kudwa, Sam Miller, Jon Fitzpatrick, Judy Watson-Johnson, Nicole Keating, Melinda Ruiz, Richard Mushlin, William Alosio, Kristi McConnell,[...]. PLoS One 2012
237
5

Genetics and neuropathology of Huntington's disease.
Anton Reiner, Ioannis Dragatsis, Paula Dietrich. Int Rev Neurobiol 2011
107
5

Diagnostic criteria for Huntington's disease based on natural history.
Ralf Reilmann, Blair R Leavitt, Christopher A Ross. Mov Disord 2014
107
5

Huntington's disease.
Marianne J U Novak, Sarah J Tabrizi. BMJ 2010
148
5

International Guidelines for the Treatment of Huntington's Disease.
Anne-Catherine Bachoud-Lévi, Joaquim Ferreira, Renaud Massart, Katia Youssov, Anne Rosser, Monica Busse, David Craufurd, Ralf Reilmann, Giuseppe De Michele, Daniela Rae,[...]. Front Neurol 2019
44
11

Living with Huntington's disease: need for supportive care.
Sky Dawson, Linda J Kristjanson, Christine M Toye, Penny Flett. Nurs Health Sci 2004
46
8

Determinants of functional disability in Huntington's disease: role of cognitive and motor dysfunction.
Christopher A Ross, Alex Pantelyat, Jane Kogan, Jason Brandt. Mov Disord 2014
61
6


Cognitive decline in Huntington's disease expansion gene carriers.
Verena Baake, Robert H A M Reijntjes, Eve M Dumas, Jennifer C Thompson, Raymund A C Roos. Cortex 2017
21
19

CAG repeat number governs the development rate of pathology in Huntington's disease.
J B Penney, J P Vonsattel, M E MacDonald, J F Gusella, R H Myers. Ann Neurol 1997
489
4

The Neuropsychology of Huntington's Disease.
Julie S Snowden. Arch Clin Neuropsychol 2017
51
7

Cognitive decline in prodromal Huntington Disease: implications for clinical trials.
Jane S Paulsen, Megan M Smith, Jeffrey D Long. J Neurol Neurosurg Psychiatry 2013
67
5

Neurocognitive signs in prodromal Huntington disease.
Julie C Stout, Jane S Paulsen, Sarah Queller, Andrea C Solomon, Kathryn B Whitlock, J Colin Campbell, Noelle Carlozzi, Kevin Duff, Leigh J Beglinger, Douglas R Langbehn,[...]. Neuropsychology 2011
253
4

HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism.
Ihn Sik Seong, Elena Ivanova, Jong-Min Lee, Yeun Su Choo, Elisa Fossale, MaryAnne Anderson, James F Gusella, Jason M Laramie, Richard H Myers, Mathieu Lesort,[...]. Hum Mol Genet 2005
219
4

Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules.
Laurent R Gauthier, Bénédicte C Charrin, Maria Borrell-Pagès, Jim P Dompierre, Hélène Rangone, Fabrice P Cordelières, Jan De Mey, Marcy E MacDonald, Volkmar Lessmann, Sandrine Humbert,[...]. Cell 2004
797
4


Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration.
Patrick Weydt, Victor V Pineda, Anne E Torrence, Randell T Libby, Terrence F Satterfield, Eduardo R Lazarowski, Merle L Gilbert, Gregory J Morton, Theodor K Bammler, Andrew D Strand,[...]. Cell Metab 2006
444
4

Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration.
Libin Cui, Hyunkyung Jeong, Fran Borovecki, Christopher N Parkhurst, Naoko Tanese, Dimitri Krainc. Cell 2006
759
4

Differential loss of striatal projection neurons in Huntington disease.
A Reiner, R L Albin, K D Anderson, C J D'Amato, J B Penney, A B Young. Proc Natl Acad Sci U S A 1988
743
4

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.
Lauren M Byrne, Filipe B Rodrigues, Kaj Blennow, Alexandra Durr, Blair R Leavitt, Raymund A C Roos, Rachael I Scahill, Sarah J Tabrizi, Henrik Zetterberg, Douglas Langbehn,[...]. Lancet Neurol 2017
172
4

Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
4

Predictors of nursing home placement in Huntington disease.
V L Wheelock, T Tempkin, K Marder, M Nance, R H Myers, H Zhao, E Kayson, C Orme, I Shoulson. Neurology 2003
86
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.